A detailed history of Sterling Investment Advisors, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Sterling Investment Advisors, Ltd. holds 12,865 shares of AMGN stock, worth $3.39 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
12,865
Previous 12,963 0.76%
Holding current value
$3.39 Million
Previous $4.05 Million 2.35%
% of portfolio
1.12%
Previous 1.16%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$309.38 - $337.38 $30,319 - $33,063
-98 Reduced 0.76%
12,865 $4.15 Million
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $256,969 - $312,285
978 Added 8.16%
12,963 $4.05 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $160,515 - $193,762
597 Added 5.24%
11,985 $3.41 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $70,317 - $79,326
275 Added 2.47%
11,388 $3.28 Million
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $199,627 - $247,842
-913 Reduced 7.59%
11,113 $2.99 Million
Q2 2023

Aug 03, 2023

SELL
$214.27 - $253.37 $127,062 - $150,248
-593 Reduced 4.7%
12,026 $2.67 Million
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $102,282 - $124,665
-453 Reduced 3.47%
12,619 $3.05 Million
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $253,078 - $321,566
-1,105 Reduced 7.79%
13,072 $3.43 Million
Q3 2022

Nov 03, 2022

BUY
$224.46 - $253.15 $50,727 - $57,211
226 Added 1.62%
14,177 $3.2 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $260,702 - $290,116
1,130 Added 8.81%
13,951 $3.39 Million
Q1 2022

May 03, 2022

BUY
$219.27 - $242.57 $29,601 - $32,746
135 Added 1.06%
12,821 $3.1 Million
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $18,042 - $21,139
-85 Reduced 0.67%
12,686 $2.7 Million
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $78,950 - $87,589
338 Added 2.72%
12,771 $3.11 Million
Q1 2021

May 04, 2021

BUY
$221.91 - $258.6 $21,081 - $24,567
95 Added 0.77%
12,433 $3.09 Million
Q4 2020

Jan 21, 2021

BUY
$216.38 - $257.67 $19,474 - $23,190
90 Added 0.73%
12,338 $2.84 Million
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $9,386 - $10,438
-40 Reduced 0.33%
12,248 $3.11 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $27,336 - $36,255
150 Added 1.24%
12,288 $2.49 Million
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $17,411 - $20,862
100 Added 0.83%
12,138 $2.35 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $226,211 - $265,171
-1,357 Reduced 10.13%
12,038 $2.22 Million
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $100,021 - $112,745
553 Added 4.31%
13,395 $2.55 Million
Q4 2018

Jan 18, 2019

SELL
$178.4 - $208.25 $30,863 - $36,027
-173 Reduced 1.33%
12,842 $2.5 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $32,240 - $36,346
174 Added 1.36%
13,015 $2.7 Million
Q2 2018

Jul 26, 2018

BUY
$166.05 - $186.51 $4,151 - $4,662
25 Added 0.2%
12,841 $2.37 Million
Q1 2018

Apr 23, 2018

SELL
$169.43 - $198.0 $35,241 - $41,184
-208 Reduced 1.6%
12,816 $2.19 Million
Q4 2017

Jan 29, 2018

BUY
$168.79 - $188.59 $71,735 - $80,150
425 Added 3.37%
13,024 $2.27 Million
Q3 2017

Nov 03, 2017

SELL
$167.29 - $191.0 $25,093 - $28,650
-150 Reduced 1.18%
12,599 $2.35 Million
Q2 2017

Aug 09, 2017

BUY
N/A
12,749
12,749 $2.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sterling Investment Advisors, Ltd. Portfolio

Follow Sterling Investment Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.